<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about ADUS</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Wed, 19 Jun 2013 19:20:57 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=ADUS" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/your-next-stock-should-be-making-new-highs-screen-of-the-week-cm254133">
      <guid isPermaLink="false">254133</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7eBn8vMf9T8/your-next-stock-should-be-making-new-highs-screen-of-the-week-cm254133</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>Your Next Stock Should Be Making New Highs - Screen of the Week</title>
      <description>Today I'm going to go over a simple screen with a powerful concept.   Buying stocks making new highs. I know some are reluctant to buy stocks making new 52 weeks highs. If you're one of them,&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/7eBn8vMf9T8" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 18 Jun 2013 10:46:01 Z</pubDate>
      <a10:updated>2013-06-18T20:37:22Z</a10:updated>
      <author>Kevin Matras</author>
      <nasdaq:tickers>ADUS</nasdaq:tickers>
      <nasdaq:tickers>AMWD</nasdaq:tickers>
      <nasdaq:tickers>BLMN</nasdaq:tickers>
      <nasdaq:tickers>MGA</nasdaq:tickers>
      <nasdaq:tickers>OMG</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/your-next-stock-should-be-making-new-highs-screen-of-the-week-cm254133</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/balanced-view-on-davita-analyst-blog-cm252124">
      <guid isPermaLink="false">252124</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MMDwsXMmn28/balanced-view-on-davita-analyst-blog-cm252124</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Balanced View on DaVita - Analyst Blog</title>
      <description>We have reiterated our Neutral recommendation on  DaVita HealthCare Partners Inc.  (  DVA  ) based on the various positives, which offset the negative factors such as higher expenses and high&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/MMDwsXMmn28" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 11 Jun 2013 02:27:05 Z</pubDate>
      <a10:updated>2013-06-10T23:28:11Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ADUS</nasdaq:tickers>
      <nasdaq:tickers>DVA</nasdaq:tickers>
      <nasdaq:tickers>HLS</nasdaq:tickers>
      <nasdaq:tickers>LCAV</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/balanced-view-on-davita-analyst-blog-cm252124</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/anatomy-of-success-addus-homecare-adus-anatomy-of-success-cm250707">
      <guid isPermaLink="false">250707</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2Lmpw4YJMSM/anatomy-of-success-addus-homecare-adus-anatomy-of-success-cm250707</link>
      <category>Investing</category>
      <category>Stocks</category>
      <title>Anatomy of Success: Addus HomeCare (ADUS) - Anatomy of Success</title>
      <description>ADDUS HOMECARE (ADUS): Free Stock Analysis Report    To read this article on Zacks.com click here.    Zacks Investment Research&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/2Lmpw4YJMSM" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 04 Jun 2013 10:10:01 Z</pubDate>
      <a10:updated>2013-06-05T11:31:03Z</a10:updated>
      <author>Kevin Matras</author>
      <nasdaq:tickers>ADUS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/anatomy-of-success-addus-homecare-adus-anatomy-of-success-cm250707</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/addus-homecare-adus-anatomy-of-success-cm251083">
      <guid isPermaLink="false">251083</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tW7aFuHfBWE/addus-homecare-adus-anatomy-of-success-cm251083</link>
      <category>Investing</category>
      <category>Stocks</category>
      <title>Addus HomeCare (ADUS) - Anatomy of Success</title>
      <description>Stocks with rising earnings estimate revisions are more likely to go up, while stocks with falling earnings estimate revisions are more likely to go down.   This makes sense on many levels. As&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/tW7aFuHfBWE" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 04 Jun 2013 10:10:01 Z</pubDate>
      <a10:updated>2013-06-05T20:34:00Z</a10:updated>
      <author>Kevin Matras</author>
      <nasdaq:tickers>ADUS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/addus-homecare-adus-anatomy-of-success-cm251083</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/gentiva-falls-to-underperform-analyst-blog-cm249534">
      <guid isPermaLink="false">249534</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WqsiC_bj6OE/gentiva-falls-to-underperform-analyst-blog-cm249534</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Gentiva Falls to Underperform - Analyst Blog</title>
      <description>On May 28, 2013, we downgraded  Gentiva Health Services Inc.  (  GTIV  ) to Underperform from Neutral based on its weak first-quarter earnings on the back of consistently declining revenues&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/WqsiC_bj6OE" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 30 May 2013 02:29:02 Z</pubDate>
      <a10:updated>2013-05-29T23:30:23Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ADUS</nasdaq:tickers>
      <nasdaq:tickers>CMS</nasdaq:tickers>
      <nasdaq:tickers>GTIV</nasdaq:tickers>
      <nasdaq:tickers>HLS</nasdaq:tickers>
      <nasdaq:tickers>MOH</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/gentiva-falls-to-underperform-analyst-blog-cm249534</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/weak-1q-earnings-for-gentiva-analyst-blog-cm244929">
      <guid isPermaLink="false">244929</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kG-pwploEfA/weak-1q-earnings-for-gentiva-analyst-blog-cm244929</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Weak 1Q Earnings for Gentiva - Analyst Blog</title>
      <description>Gentiva Health Services Inc.  (  GTIV  ) reported first-quarter 2013 operating earnings of 23 cents per share, which lagged the Zacks Consensus Estimate of 31 cents as well as the year-ago&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/kG-pwploEfA" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 09 May 2013 19:25:01 Z</pubDate>
      <a10:updated>2013-05-09T16:26:11Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ADUS</nasdaq:tickers>
      <nasdaq:tickers>DVA</nasdaq:tickers>
      <nasdaq:tickers>GTIV</nasdaq:tickers>
      <nasdaq:tickers>HLS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/weak-1q-earnings-for-gentiva-analyst-blog-cm244929</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/davita-reports-strong-1q-earnings-analyst-blog-cm244759">
      <guid isPermaLink="false">244759</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LSSNtfeumfU/davita-reports-strong-1q-earnings-analyst-blog-cm244759</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>DaVita Reports Strong 1Q Earnings - Analyst Blog</title>
      <description>DaVita Reports Strong 1Q Earnings    DaVita HealthCare Partners Inc.  (  DVA  ) reported first-quarter 2013 operating earnings of $1.84 per share, beating the Zacks Consensus Estimate of $1.78&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/LSSNtfeumfU" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 09 May 2013 02:20:01 Z</pubDate>
      <a10:updated>2013-05-09T12:27:46Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ADUS</nasdaq:tickers>
      <nasdaq:tickers>DVA</nasdaq:tickers>
      <nasdaq:tickers>HLS</nasdaq:tickers>
      <nasdaq:tickers>LHCG</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/davita-reports-strong-1q-earnings-analyst-blog-cm244759</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/amedysis-reports-1q-prelim-earnings-analyst-blog-cm241256">
      <guid isPermaLink="false">241256</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7v1UARFcP_I/amedysis-reports-1q-prelim-earnings-analyst-blog-cm241256</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Amedysis Reports 1Q Prelim Earnings - Analyst Blog</title>
      <description>Home Health and Hospice Company,  Amedisys Inc.  (  AMED  ) announced its first quarter 2013 preliminary results yesterday. The company expects to report the quarter's earnings per share (EPS)&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/7v1UARFcP_I" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 26 Apr 2013 23:50:01 Z</pubDate>
      <a10:updated>2013-04-26T21:25:58Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ADUS</nasdaq:tickers>
      <nasdaq:tickers>AMED</nasdaq:tickers>
      <nasdaq:tickers>CHE</nasdaq:tickers>
      <nasdaq:tickers>CO</nasdaq:tickers>
      <nasdaq:tickers>EPS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/amedysis-reports-1q-prelim-earnings-analyst-blog-cm241256</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/coventry-upgraded-to-strong-buy-analyst-blog-cm236010">
      <guid isPermaLink="false">236010</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TiciuFqgu0g/coventry-upgraded-to-strong-buy-analyst-blog-cm236010</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Coventry Upgraded to Strong Buy - Analyst Blog</title>
      <description>On Apr 10, 2013, Zacks Investment Research upgraded  Coventry Health Care Inc.  (  CVH  ) to a Zacks Rank #1 (Strong Buy).   Why the Upgrade?   Coventry has strong fundamentals, including&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/TiciuFqgu0g" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 11 Apr 2013 21:08:41 Z</pubDate>
      <a10:updated>2013-04-11T18:12:20Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ADUS</nasdaq:tickers>
      <nasdaq:tickers>AET</nasdaq:tickers>
      <nasdaq:tickers>CVH</nasdaq:tickers>
      <nasdaq:tickers>HNT</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/coventry-upgraded-to-strong-buy-analyst-blog-cm236010</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/davita-hit-52week-high-analyst-blog-cm233453">
      <guid isPermaLink="false">233453</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YxGOQMG8L1c/davita-hit-52week-high-analyst-blog-cm233453</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>DaVita Hit 52-Week High - Analyst Blog</title>
      <description>On Apr 2, 2013, shares of  DaVita HealthCare Partners Inc.  (  DVA  ) hit a 52-week high of $128.74.  In Jan 2013, DaVita acquired 5 dialysis centers in Portugal and 4 in Poland from rival&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/YxGOQMG8L1c" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 04 Apr 2013 03:07:55 Z</pubDate>
      <a10:updated>2013-04-04T00:08:04Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ADUS</nasdaq:tickers>
      <nasdaq:tickers>CO</nasdaq:tickers>
      <nasdaq:tickers>DVA</nasdaq:tickers>
      <nasdaq:tickers>LCAV</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/davita-hit-52week-high-analyst-blog-cm233453</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/gentiva-downgraded-to-strong-sell-analyst-blog-cm230665">
      <guid isPermaLink="false">230665</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GM1sFhE5TiU/gentiva-downgraded-to-strong-sell-analyst-blog-cm230665</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Gentiva Downgraded to Strong Sell - Analyst Blog</title>
      <description>On Mar 23, 2013, Zacks Investment Research downgraded  Gentiva Health Services Inc.  (  GTIV  ) to a Zacks Rank #5 (Strong Sell).   Why the Downgrade?   Gentiva has witnessed a downturn in&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/GM1sFhE5TiU" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 26 Mar 2013 02:29:38 Z</pubDate>
      <a10:updated>2013-03-25T23:30:30Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ADUS</nasdaq:tickers>
      <nasdaq:tickers>CVH</nasdaq:tickers>
      <nasdaq:tickers>GTIV</nasdaq:tickers>
      <nasdaq:tickers>LCAV</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/gentiva-downgraded-to-strong-sell-analyst-blog-cm230665</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/gentivas-2013-guidance-disappoints-analyst-blog-cm229343">
      <guid isPermaLink="false">229343</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gOxO80fxXBU/gentivas-2013-guidance-disappoints-analyst-blog-cm229343</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Gentiva's 2013 Guidance Disappoints - Analyst Blog</title>
      <description>Recently,  Gentiva Health Services Inc.  (  GTIV  ) released it financial guidance for 2013. The company expects adjusted income from continuing operations between 90 cents and $1.10 per share,&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/gOxO80fxXBU" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 21 Mar 2013 17:34:05 Z</pubDate>
      <a10:updated>2013-03-21T14:36:08Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ADUS</nasdaq:tickers>
      <nasdaq:tickers>CVH</nasdaq:tickers>
      <nasdaq:tickers>GTIV</nasdaq:tickers>
      <nasdaq:tickers>LCAV</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/gentivas-2013-guidance-disappoints-analyst-blog-cm229343</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/zacks-rank-1-addition-for-monday-tale-of-the-tape-cm228058">
      <guid isPermaLink="false">228058</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UgByw8O0vxg/zacks-rank-1-addition-for-monday-tale-of-the-tape-cm228058</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>Zacks Rank #1 Addition for Monday  - Tale of the Tape</title>
      <description>Here are 5 stocks added to the Zacks Rank #1 ("strong buy") List today:    Addus Homecare Corp.  (  ADUS  )   Advent Software, Inc.  (  ADVS  )   CVR Partners LP  (  UAN  )   Ducommun&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/UgByw8O0vxg" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 18 Mar 2013 17:44:01 Z</pubDate>
      <a10:updated>2013-03-18T14:53:15Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ADUS</nasdaq:tickers>
      <nasdaq:tickers>ADVS</nasdaq:tickers>
      <nasdaq:tickers>DCO</nasdaq:tickers>
      <nasdaq:tickers>EGAN</nasdaq:tickers>
      <nasdaq:tickers>UAN</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/zacks-rank-1-addition-for-monday-tale-of-the-tape-cm228058</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/premarket-earnings-report-for-march-13-2013-kro-eslt-expr-ah-phmd-snss-gsol-amrc-ta-tree-dsco-adus-cm226415">
      <guid isPermaLink="false">226415</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fVvuwKcGKXA/premarket-earnings-report-for-march-13-2013-kro-eslt-expr-ah-phmd-snss-gsol-amrc-ta-tree-dsco-adus-cm226415</link>
      <category>News Headlines</category>
      <category>Earnings</category>
      <title>Pre-Market Earnings Report for March 13, 2013 :  KRO, ESLT, EXPR, AH, PHMD, SNSS, GSOL, AMRC, TA, TREE, DSCO, ADUS</title>
      <description>The following companies are expected to report earnings prior to market open on 03/13/2013. Visit our  Earnings Calendar  for a full list of expected earnings releases.   Kronos Worldwide Inc  (&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/fVvuwKcGKXA" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 13 Mar 2013 00:00:04 Z</pubDate>
      <a10:updated>2013-03-12T20:09:37Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>ADUS</nasdaq:tickers>
      <nasdaq:tickers>AH</nasdaq:tickers>
      <nasdaq:tickers>AMRC</nasdaq:tickers>
      <nasdaq:tickers>DSCO</nasdaq:tickers>
      <nasdaq:tickers>ESLT</nasdaq:tickers>
      <nasdaq:tickers>EXPR</nasdaq:tickers>
      <nasdaq:tickers>GSOL</nasdaq:tickers>
      <nasdaq:tickers>KRO</nasdaq:tickers>
      <nasdaq:tickers>PHMD</nasdaq:tickers>
      <nasdaq:tickers>SNSS</nasdaq:tickers>
      <nasdaq:tickers>TA</nasdaq:tickers>
      <nasdaq:tickers>TREE</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/premarket-earnings-report-for-march-13-2013-kro-eslt-expr-ah-phmd-snss-gsol-amrc-ta-tree-dsco-adus-cm226415</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/zacks-rank-1-additions-for-thursday-tale-of-the-tape-cm210393">
      <guid isPermaLink="false">210393</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qEMl9Xb2zso/zacks-rank-1-additions-for-thursday-tale-of-the-tape-cm210393</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>Zacks Rank #1 Additions for Thursday  - Tale of the Tape</title>
      <description>Here are 5 stocks added to the Zacks Rank #1 ("strong buy") List  today:    Abercrombie &amp;amp; Fitch Co.  (  ANF  )   Access National Corp.  (  ANCX  )   Addus Homecare Corp.  (&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/qEMl9Xb2zso" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 24 Jan 2013 18:44:01 Z</pubDate>
      <a10:updated>2013-01-24T15:22:39Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ADUS</nasdaq:tickers>
      <nasdaq:tickers>AGEN</nasdaq:tickers>
      <nasdaq:tickers>ANCX</nasdaq:tickers>
      <nasdaq:tickers>ANF</nasdaq:tickers>
      <nasdaq:tickers>BKMU</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/zacks-rank-1-additions-for-thursday-tale-of-the-tape-cm210393</feedburner:origLink></item>
  </channel>
</rss>
